FDA Drug Recalls and Warnings: Sterility Issues in Compounded GLP-1s, Antidepressants With Elevated Cancer-Linked Chemicals and More
FDA Drug Recalls and Warnings: Sterility Issues in Compounded GLP-1s, Antidepressants With Elevated Cancer-Linked Chemicals and More
MedShadow ArticlesThe FDA’s New Drug Ad Rules Are Here. Will They Actually Change Anything?Emma Yasinski
MedShadow ArticlesMedical Journals Have Flaws, But Government Oversight Isn’t the FixSuzanne B. Robotti
MedShadow ArticlesFDA SIDE EFFECTS UPDATE: Gadolinium Contrast Agents (GBCAs) and Lung ProblemsKatie Rowley
MedShadow ArticlesHeart Failure Drug Rejected, Rejected Again, Then Approved, What’s Up?Emma Yasinski
MedShadow ArticlesHeart Damage: The Silent Cost of Beating Breast CancerCarly Kay and Farah Aziz Annesha
MedShadow ArticlesFDA SIDE EFFECTS UPDATE: Remicade and the Onset of New Autoimmune Diseases, Plus MoreKatie Rowley
MedShadow ArticlesFrom Ashwagandha to St. John’s Wort: The Risks Behind 5 Trending SupplementsJessie Sebor
MedShadow ArticlesThe Unsettling Truth About Ciprofloxacin: A Wonder Drug’s Darker SideKristel Tjandra, Ph.D., Madeline Reinsel and Gillian Dohrn
MedShadow ArticlesINVESTIGATING GENERICS: Decades of Recalls Reveal Flaws in the U.S. Opioid Supply Chain Emma Yasinski
